DD276479A1 - PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES - Google Patents
PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES Download PDFInfo
- Publication number
- DD276479A1 DD276479A1 DD32107488A DD32107488A DD276479A1 DD 276479 A1 DD276479 A1 DD 276479A1 DD 32107488 A DD32107488 A DD 32107488A DD 32107488 A DD32107488 A DD 32107488A DD 276479 A1 DD276479 A1 DD 276479A1
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- fur
- item
- benzo
- methyl
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 16
- 125000005605 benzo group Chemical group 0.000 claims abstract description 7
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 5
- 238000007363 ring formation reaction Methods 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 6
- YRBOHGKODLAVAT-UHFFFAOYSA-N 2-(phenoxymethyl)quinoxaline Chemical class C=1N=C2C=CC=CC2=NC=1COC1=CC=CC=C1 YRBOHGKODLAVAT-UHFFFAOYSA-N 0.000 claims description 5
- 239000002585 base Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000011541 reaction mixture Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 150000003252 quinoxalines Chemical class 0.000 claims description 3
- QHCWJHQEBKERCS-UHFFFAOYSA-N 2-(bromomethyl)-3-methylquinoxaline Chemical compound C1=CC=C2N=C(CBr)C(C)=NC2=C1 QHCWJHQEBKERCS-UHFFFAOYSA-N 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000000155 melt Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 239000003619 algicide Substances 0.000 abstract description 2
- 239000004009 herbicide Substances 0.000 abstract description 2
- 239000000543 intermediate Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- -1 3-methyl-substituted quinoxalines Chemical class 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 125000005997 bromomethyl group Chemical group 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- FJXUHBROUDEKBH-UHFFFAOYSA-N 1-(1-benzofuran-2-yl)propan-1-one Chemical class C1=CC=C2OC(C(=O)CC)=CC2=C1 FJXUHBROUDEKBH-UHFFFAOYSA-N 0.000 description 1
- JESVEEDFBPRGPM-UHFFFAOYSA-N 2-[(3-methylquinoxalin-2-yl)methoxy]benzaldehyde Chemical compound CC1=NC2=CC=CC=C2N=C1COC1=CC=CC=C1C=O JESVEEDFBPRGPM-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical compound OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- XTUZDTPJYCKPKF-UHFFFAOYSA-N CC=1C(=NC2=CC=CC=C2N1)COC1=C(C(=O)C2=CC=CC=C2)C=C(C=C1)C Chemical compound CC=1C(=NC2=CC=CC=C2N1)COC1=C(C(=O)C2=CC=CC=C2)C=C(C=C1)C XTUZDTPJYCKPKF-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 150000002240 furans Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- JUACUZDAEZJGKH-UHFFFAOYSA-N methyl 2-[(3-methylquinoxalin-2-yl)methoxy]benzoate Chemical compound COC(=O)C1=CC=CC=C1OCC1=NC2=CC=CC=C2N=C1C JUACUZDAEZJGKH-UHFFFAOYSA-N 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Die Erfindung betrifft ein neues Verfahren zur Herstellung bisher schlecht zugaenglicher Benzo&b!fur-2-ylchinoxaline (Formel I), die als Zwischenprodukte zur Zubereitung biologisch aktiver Praeparate, insbesondere von algiziden und herbiziden Mitteln, anwendbar sind. Die Synthese erfolgt durch Cyclisierung von substiutierten Phenoxymethylchinoxalinen der allgemeinen Formel II durch Einwirkung starker Basen.The invention relates to a novel process for preparing benzo & b! Fur-2-ylquinoxalines (formula I), which have hitherto been difficult to access, and which can be used as intermediates for the preparation of biologically active preparations, in particular of algicides and herbicides. The synthesis is carried out by cyclization of substiutierten Phenoxymethylchinoxalinen the general formula II by the action of strong bases.
Description
Anwendungsgebiet der ErfindungField of application of the invention
Die Erfindung betrifft ein Verfahren zur Herstellung von Benzolblfur-2-ylchinoxalinen, die als Zwischenprodukte zur Zubereitung biologisch aktiver Präparate, Insbesondere von algiziden und herbiziden Mitteln, anwendbar sind.The invention relates to a process for the preparation of Benzolblfur-2-ylquinoxalines, which are useful as intermediates for the preparation of biologically active preparations, in particular of algicides and herbicidal agents.
Charakteristik der bekannten technischen LösungenCharacteristic of the known technical solutions
Benzo[b]fur-2-y!chinoxaline haben sich als biologisch akliv erwiesen und werden bisher durch Oxidation, Bromierung oder Isonitrosierung von 2-Acyl-benzo|b)furanen und Cycüsie-ung der Reaktionsprodukte mit o-l'henylendiamin hergestellt DD-PS 258 165A1 worn 13.7.88). Dieses Verfahren liefert zwar die entsorechenden 3-unsubstituierten Chinoxaline mit guten Ergebnissen. Es hat aber den Nachteil, daß die 3-methylsubetituiorten Chinoxaline (Formel I) schlecht zugänglich sird, da die als Ausgangsstoffe benötigten 2-Propionyl-benzo|b)furane v/esentlich schwieriger herstellbar sind als die im linderen fall benutzten 2-Acetyl-bonzo|b]furane. Sollen nämlich die 2-Propionyl-benzo|b)furano nach dem gleichen Synthesepririzip wie die 2-Acetylbenzo|b|furane gewonnen worden, bonötigt man das 1 -Halogen-butan-2-on, das aber bei der Halogenierung von Butanon nur in geringer Mengo neben dem als Hauptprodukt anfallenden 3-Halogen-butan-2-on entsteht. Deshalb wurdo das 2-Propionylbenzo|b]furan bisher nicht auf diose Weise, sondern im Ergebnis von mehrstufigen Synthosen unter Benutzung von silicium- bzw. metallorganischen Reaktionspartnern hergestellt (A.ch. (11)17 [1942] 335; Tetrahedron 40(1984] 621). Bei dem bekannten, nachteiligen Verfahren wird zuer.st der Benzofuran- und danach der fhinoxa'in-Ringschluß vollzogen.Benzo [b] fur-2-yl quinoxalines have been found to be biologically active and have previously been prepared by oxidation, bromination or isonitrosation of 2-acyl-benzo [b] furans and cycloaddition of the reaction products with o-1-phenylenediamine DD -PS 258 165A1 worn 13.7.88). Although this process provides the 3-unsubstituted quinoxalines having good results. However, it has the disadvantage that the 3-methyl-substituted quinoxalines (formula I) are poorly accessible, since the 2-propionyl-benzo [b] furans required as starting materials are in some cases more difficult to prepare than the 2-acetylbenzenes used in the lesser case. bonzo | b] furans. If the 2-propionyl-benzo | b) furano were to be obtained according to the same synthesis protocol as the 2-acetylbenzo | b | furane, the 1-halo-butan-2-one is required, but only in the case of the halogenation of butanone low Mengo arises next to the main product incurred as 3-halo-butan-2-one. Therefore, 2-propionylbenzo | b] furan has not been synthesized in the dioxygen fashion, but as a result of multistep syntheses using organosilicon or organometallic reagents (A.ch. (11) 17 [1942] 335, Tetrahedron 40 (1984 ] 621). In the known, disadvantageous process, at first the benzofuran and then the fhinoxa'in ring closure are carried out.
Ziel der ErfindungObject of the invention
Ziel der Erfindung ist es, ein neues Verfahren zur Herstellung von solchen 8enzo|b]fur-2-ylch!noxalinen zu finden, die bisher schlecht zugänglich sind. Das neue Verfahren soll dem bisher bekannten überlegen sein un J die bisher schlecht zugänglichen 2-(Benzo(b]fur-2-yl)-3-methyl-chinoxaline (Formel I) leichter herzustellen gestatten.The aim of the invention is to find a new process for the preparation of such 8enzo b] fur-2-ylch! Noxalinen, which are currently difficult to access. The new process should be superior to those known hitherto and make it easier to prepare the previously poorly accessible 2- (benzo (b) fur-2-yl) -3-methylquinoxalines (formula I).
Darlegung des Wesens der ErfindungExplanation of the essence of the invention
Aufgabe der Erfindung ist es, ein neues Verfahren zur Herstellung von Benzofb|fur-2-ylchinoxalinen zu finden, die in 3-Stellung des Chinoxalins rnethylsubstituiert sind, da derartige Verbindungen biologische Aktivität aufweisen, bisher aber schlecht zugänglich sind. Dabei soll im Gegensatz zu dem bisherigen Verfahren ein Ausgangsstoff mit vorgefertigtem Chinoxalinsystem eingesetzt werden, an dem im Synthesevorlauf der Benzofuran-Ringschluß vollzogen wird.The object of the invention is to find a novel process for the preparation of Benzofb | fur-2-ylquinoxalines, which are methyl-substituted in the 3-position of quinoxaline, since such compounds have biological activity, but are so far poorly accessible. In contrast to the previous process, a starting material with a prefabricated quinoxaline system should be used, in which the benzofuran ring closure is carried out in the synthesis process.
Erfindungsgemäß wird die Aufgabe dadurch gelöst, daß die aus 2-(Brommethyl)-3-methyl-chinoxartn und aromatischen o-Hydroxy-carbonyl-Verbindungen gut zugänglichen Phenoxvmethylchinoxaline (z.B. DD-PS 258226A1 vom 13.7.1988) der allgemeinen Formel II, in der R und R' unabhängig voneinander H, Alkyl, Aryl, Alkoxy oder Aroxy boc'euten können, in der Schmelze oder in Lösung, wobei bevorzugt handelsübliches oder absolutes Ethanol als Lösungsmittel benutzt wird, durch Einwirkung starker Basen, bevorzugt Alkalihydroxid oder Alkaliethanolat, in mindestens äquimolarer Menge bei Temperaturen von 0°C bis 2500C, bevorzugt bei der Siedetemperatur des Lösungsmittels, cyclisiert werden, wobei d e 2-(Benzo[b]fur-2-ylj-3-methyl-chinoxaline der allgemeinen Formel I, in der R » H, OH, Alkyl oder Aryl bedeutet und R' die gleiche Bedeutung wie im eingosotzten Phenoxymethylchinoxalin besitzt, entstehen. Wie aus den Beispielen 2 und 3 erkennbar i it, kann das Verfahren vorteilhaft auch so durchgeführt werden, df>3 das zu cyclisierende Phenoxymethylchinoxalin nicht als Substanz isoliert wird, sondern nach seiner Bildung aus den o.g. Ausgangsstoffen in gelöster Form als Bestandteil des Reaktior sgemisches mit der die Cyclisiorung bewirkenden Base versetzt wird.According to the invention the object is achieved in that the readily available from 2- (bromomethyl) -3-methyl-quinoxartn and aromatic o-hydroxy-carbonyl compounds Phenoxvmethylchinoxaline (eg DD-PS 258226A1 of 13.7.1988) of the general formula II, in R and R 'independently of one another can be H, alkyl, aryl, alkoxy or hydroxyalkyl, in the melt or in solution, preference being given to using commercial or absolute ethanol as solvent, by the action of strong bases, preferably alkali metal hydroxide or alkali metal ethanolate at least equimolar amount at temperatures from 0 ° C to 250 0 C, preferably at the boiling temperature of the solvent, cyclized, wherein de 2- (benzo [b] fur-2-ylj-3-methyl-quinoxalines of the general formula I, in R 'is H, OH, alkyl or aryl and R' has the same meaning as in the eingosotzten phenoxymethylquinoxaline arise.As it can be seen from Examples 2 and 3 i it, the process may advantageously also Runaway are led, df> 3 the phenoxymethylquinoxaline to be cyclized is not isolated as a substance, but after its formation from the above-mentioned starting materials in dissolved form as a component of the reaction mixture is mixed with the base causing the Cyclisiorung.
CH3 OCCH 3 OC
CH2-OCH 2 -O
R /R /
BeUpIeM:BeUpIeM:
2-(Benzo|b)fur-2-yl)-3-mothylchinoxalin2- (benzo | b) fur-2-yl) -3-mothylchinoxalin
27,8 TI. 2-(3-Methyl-chinoxalin-2-ylmethoxyibenzaldehyd werden in 220 TI. Ethanol gelöst und mit dor Lösung von 6 TI.27.8 TI. 2- (3-Methyl-quinoxalin-2-ylmethoxybenzaldehyde are dissolved in 220 μl of ethanol and dissolved with the 6 TI solution.
wird abgesaugt, mit Wasser neutral gewaschen und aus Ethanol umkristallisiert.is filtered off with suction, washed neutral with water and recrystallized from ethanol.
Beleplel 2:Belelplel 2:
?-(Denzo|b)fur-2-yl)-3-methyl-chinoxalin? - (Denzo | b) fur-2-yl) -3-methyl-quinoxaline
23,7 TI. 2-{Brommothyl)-3-methyl-chinoxalin in 400 TI. Ethanol versetzt. Man kocht 1 Stunde unter Rückfluß, fügt erneut β TI.23.7 TI. 2- {bromomethyl) -3-methylquinoxaline in 400 TI. Ethanol added. Boil for 1 hour under reflux, again adding β TI.
wird abgesaugt, mit Wasser neutral gewaschen und aus Ethanol umkristallisiert.is filtered off with suction, washed neutral with water and recrystallized from ethanol.
Ausbeute 82%.Yield 82%.
2-Methyl-3-(3-methyl-benzolb]fur-2-yl)chinoxt\lin2-methyl-3- (3-methyl-benzolb] fur-2-yl) chinoxt \ lin
2-Hydroxy-acetophenon und danach eina Lösung von 23,7 TI. 2-(Brommethyl)-3-methyl-chinoxa!in in 320 TI. sbsolutem Ethanolhinzu und kocht 2 Stunden unter Rückfluß. Da» Reaktionsgemiech wird erneut mit 2,5 TI. Natrium, gelöst in 30 TI. absolutem2-Hydroxy-acetophenone and then a solution of 23.7 TI. 2- (bromomethyl) -3-methyl-quinoxal! In 320 TI. absolute ethanol and boiled for 2 hours under reflux. Since the reaction mixture is again 2.5 TI. Sodium, dissolved in 30 TI. absolute
BeUpIeU:BeUpIeU:
2-Methyl-3-(5-methyl-3-phenyl-benzo[b)fur-2-yl)chinoxalin2-Methyl-3- (5-methyl-3-phenyl-benzo [b) fur-2-yl) quinoxaline
wird 3 Stunden unter Rückfluß gekocht und anschließend im Vakuum eingeengt. Das Produkt wird kalt abgesaugt, mit Wasserneutral gewaschen und aus Ethanol umkristailisiert.is refluxed for 3 hours and then concentrated in vacuo. The product is filtered off with suction, washed with water neutral and recrystallised from ethanol.
Beispiels: 2-(6-Methoxy-3-phenyl-benzo[blfur-2-yl)-3-methyl-chinoxalinExample: 2- (6-Methoxy-3-phenyl-benzo [blur-2-yl) -3-methyl-quinoxaline
a) Analog Beispiel 2 mit 25 TI. 2-Hydroxy-4-methoxy-benzophenon; die vereinigten ethanolischen Lösungen werden im Vakuum eingeengt und zur Kristallisation in den Kühlschrank gestellt;a) Analogously to Example 2 with 25 TI. 2-hydroxy-4-methoxy-benzophenone; The combined ethanolic solutions are concentrated in vacuo and placed in the refrigerator for crystallization;
b) Analog Beispiel 4 mit 38,4 TI. 4Methoxy-2-(3-mMhyl-chlnoxalin-2-ylmethoxy)benzophenon, Ausbeute 73 % der Theorie.b) Analogously to Example 4 with 38.4 TI. 4-Methoxy-2- (3-methyl-2-oxyn-2-ylmethoxy) benzophenone, yield 73% of theory.
Beispiel β:Example β:
2-(3-Hydroxy-benzo[b)fur-2-yl)-3-methyl-chinoxalin2- (3-hydroxy-benzo [b) fur-2-yl) -3-methyl-quinoxaline
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD32107488A DD276479A1 (en) | 1988-10-26 | 1988-10-26 | PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD32107488A DD276479A1 (en) | 1988-10-26 | 1988-10-26 | PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD276479A1 true DD276479A1 (en) | 1990-02-28 |
Family
ID=5603403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD32107488A DD276479A1 (en) | 1988-10-26 | 1988-10-26 | PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD276479A1 (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9018210B2 (en) | 2011-12-28 | 2015-04-28 | Global Blood Therapeutics, Inc. | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9447071B2 (en) | 2014-02-07 | 2016-09-20 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US9957250B2 (en) | 2013-03-15 | 2018-05-01 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9981939B2 (en) | 2013-03-15 | 2018-05-29 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10077249B2 (en) | 2016-05-12 | 2018-09-18 | Global Blood Therapeutics, Inc. | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US11014884B2 (en) | 2018-10-01 | 2021-05-25 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin |
-
1988
- 1988-10-26 DD DD32107488A patent/DD276479A1/en not_active IP Right Cessation
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10034879B2 (en) | 2011-12-28 | 2018-07-31 | Global Blood Therapeutics, Inc. | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9012450B2 (en) | 2011-12-28 | 2015-04-21 | Global Blood Therapeutics, Inc. | Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9018210B2 (en) | 2011-12-28 | 2015-04-28 | Global Blood Therapeutics, Inc. | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US10806733B2 (en) | 2011-12-28 | 2020-10-20 | Global Blood Therapeutics, Inc. | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100040B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9776960B2 (en) | 2013-03-15 | 2017-10-03 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US9957250B2 (en) | 2013-03-15 | 2018-05-01 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9981939B2 (en) | 2013-03-15 | 2018-05-29 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10017491B2 (en) | 2013-03-15 | 2018-07-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10829470B2 (en) | 2013-03-15 | 2020-11-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10315991B2 (en) | 2013-03-15 | 2019-06-11 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10137118B2 (en) | 2014-02-07 | 2018-11-27 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US10722502B2 (en) | 2014-02-07 | 2020-07-28 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US9447071B2 (en) | 2014-02-07 | 2016-09-20 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US11452720B2 (en) | 2014-02-07 | 2022-09-27 | Global Blood Therapeutics, Inc. | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| US10577345B2 (en) | 2016-05-12 | 2020-03-03 | Global Blood Therapeutics, Inc. | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde |
| US10077249B2 (en) | 2016-05-12 | 2018-09-18 | Global Blood Therapeutics, Inc. | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde |
| US11014884B2 (en) | 2018-10-01 | 2021-05-25 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD276479A1 (en) | PROCESS FOR THE PREPARATION OF BENZO / B / FUR-2-YLCHINOXALINES | |
| DE1809386A1 (en) | Process for the preparation of 1,5-disubstituted 4-cyanopyrazoles | |
| EP0380712B1 (en) | Process for the preparation of 2,6-dichlorodiphenylaminoacetic-acid derivatives | |
| DD276480A1 (en) | PROCESS FOR THE PREPARATION OF NAPHTHO / 2,1-B / FUR-2-YLCHINOXALINES | |
| DE2118315C3 (en) | 2- (1H) -quinazolinone derivatives, processes for their preparation and pharmaceuticals containing these compounds | |
| DE2707102A1 (en) | PROCESS FOR REGIOSPECIFIC PRODUCTION OF O-AMINOPHENYL KETONES | |
| DE2220256C3 (en) | N- (O- OR P-NITROBENZOYL) SULFOXIMINE, PROCESS FOR THEIR PREPARATION AND USE OF THE SAME | |
| DE1935404C3 (en) | Process for the manufacture of quinazolines | |
| EP0653423B1 (en) | Process for the preparation of substituted quinazoline-2,4-diones | |
| DE4125246C1 (en) | ||
| EP0378046B1 (en) | Process for the preparation of 3-phenyl-pyrrole derivatives | |
| DE1695804C3 (en) | N Acyl 2 methyl 3 indolylcarbonic acids, process for their preparation and pharmaceuticals | |
| DE3129718A1 (en) | 4-OXIMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| DE1153375B (en) | Process for the preparation of benzoxazine- (1, 3) -dione- (2, 4) | |
| DE2811361A1 (en) | NEW ISOCHINOLINALDEHYDE AND THE METHOD OF MANUFACTURING IT | |
| DE3303704A1 (en) | 2,4-DICHLOR-5-THIAZOLE CARBOXALDEHYDE AND A METHOD FOR PRODUCING THE SAME | |
| DE2706701A1 (en) | 3-Chloro-5-halo-pyridazine derivs. prepn. - by reacting a 1,3,3,3-tetra:halo-propenyl ketone or aldehyde and cyclising the semicarbazone formed | |
| AT360537B (en) | METHOD FOR THE PRODUCTION OF NEW 1,4-DIHYDROPYRIDE IN DERIVATIVES | |
| DE2448259A1 (en) | PROCESS FOR THE PREPARATION OF 2-HALOGENMETHYL-1,4-BENZODIAZEPINES | |
| AT256863B (en) | Process for the preparation of new basic derivatives of dihydro-1, 3-benzoxazine-2, 4-dione | |
| WO2000023427A1 (en) | Method for producing optionally substituted 1-methyl-6-haloalkyl uracils | |
| DD202571A5 (en) | PROCESS FOR THE PREPARATION OF 5,11-DIHYDRO-6H-PYRIDO (2,3-B) - (1,4) BENZODIAZEPINE-6-ONEN | |
| DD292001A5 (en) | PROCESS FOR THE PREPARATION OF BENZO [B] FUER-2-YLCHINOXALINES | |
| DE1100636B (en) | Process for the preparation of 2,4-dioxo-dihydro-5,6-benz-1,3-thiazines | |
| DD272846A1 (en) | PROCESS FOR PREPARING SUBSTITUTED 2-ALKOXY-CARBONYLMETHYLENE-2H-1-BENZOPYRANE-3-CARBOXYLIC ACID ESTERS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |